JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/17 | 2,104 | 2,142 | 2,093 | 2,135 | +31 | +1.5% | 267,900 |
2022/01/14 | 2,096 | 2,105 | 2,055 | 2,104 | -21 | -1% | 435,600 |
2022/01/13 | 2,148 | 2,154 | 2,115 | 2,125 | -36 | -1.7% | 363,400 |
2022/01/12 | 2,144 | 2,175 | 2,122 | 2,161 | +16 | +0.7% | 442,100 |
2022/01/11 | 2,105 | 2,148 | 2,086 | 2,145 | +49 | +2.3% | 493,400 |
2022/01/07 | 2,100 | 2,134 | 2,061 | 2,096 | +18 | +0.9% | 658,600 |
2022/01/06 | 2,099 | 2,141 | 2,065 | 2,078 | -63 | -2.9% | 772,600 |
2022/01/05 | 2,204 | 2,216 | 2,139 | 2,141 | -86 | -3.9% | 713,300 |
2022/01/04 | 2,226 | 2,244 | 2,196 | 2,227 | +3 | +0.1% | 344,700 |
2021/12/30 | 2,229 | 2,237 | 2,211 | 2,224 | -29 | -1.3% | 226,700 |
2021/12/29 | 2,200 | 2,270 | 2,192 | 2,253 | +53 | +2.4% | 367,900 |
2021/12/28 | 2,181 | 2,201 | 2,146 | 2,200 | +23 | +1.1% | 571,800 |
2021/12/27 | 2,230 | 2,234 | 2,170 | 2,177 | -58 | -2.6% | 414,000 |
2021/12/24 | 2,248 | 2,259 | 2,207 | 2,235 | -7 | -0.3% | 338,300 |
2021/12/23 | 2,243 | 2,251 | 2,219 | 2,242 | +9 | +0.4% | 335,300 |
2021/12/22 | 2,240 | 2,260 | 2,203 | 2,233 | -21 | -0.9% | 378,800 |
2021/12/21 | 2,211 | 2,273 | 2,180 | 2,254 | +56 | +2.5% | 536,300 |
2021/12/20 | 2,168 | 2,215 | 2,159 | 2,198 | +8 | +0.4% | 456,200 |
2021/12/17 | 2,285 | 2,285 | 2,190 | 2,190 | -100 | -4.4% | 630,600 |
2021/12/16 | 2,275 | 2,295 | 2,240 | 2,290 | +65 | +2.9% | 632,700 |
2021/12/15 | 2,226 | 2,255 | 2,207 | 2,225 | -12 | -0.5% | 360,800 |
2021/12/14 | 2,261 | 2,296 | 2,230 | 2,237 | -19 | -0.8% | 424,000 |
2021/12/13 | 2,283 | 2,328 | 2,235 | 2,256 | +7 | +0.3% | 544,500 |
2021/12/10 | 2,336 | 2,337 | 2,249 | 2,249 | -114 | -4.8% | 759,800 |
2021/12/09 | 2,431 | 2,431 | 2,357 | 2,363 | -71 | -2.9% | 398,900 |
2021/12/08 | 2,422 | 2,451 | 2,400 | 2,434 | +56 | +2.4% | 468,500 |
2021/12/07 | 2,356 | 2,380 | 2,333 | 2,378 | +24 | +1% | 474,500 |
2021/12/06 | 2,448 | 2,448 | 2,350 | 2,354 | -106 | -4.3% | 496,300 |
2021/12/03 | 2,381 | 2,470 | 2,375 | 2,460 | +78 | +3.3% | 524,100 |
2021/12/02 | 2,369 | 2,438 | 2,353 | 2,382 | -10 | -0.4% | 575,200 |
2021/12/01 | 2,463 | 2,463 | 2,376 | 2,392 | -107 | -4.3% | 768,200 |
2021/11/30 | 2,568 | 2,622 | 2,495 | 2,499 | -68 | -2.6% | 464,000 |
2021/11/29 | 2,517 | 2,644 | 2,516 | 2,567 | +19 | +0.7% | 616,100 |
2021/11/26 | 2,595 | 2,596 | 2,524 | 2,548 | -39 | -1.5% | 484,900 |
2021/11/25 | 2,565 | 2,587 | 2,520 | 2,587 | +19 | +0.7% | 386,600 |
2021/11/24 | 2,630 | 2,630 | 2,522 | 2,568 | -93 | -3.5% | 791,500 |
2021/11/22 | 2,624 | 2,674 | 2,612 | 2,661 | +39 | +1.5% | 353,000 |
2021/11/19 | 2,718 | 2,719 | 2,585 | 2,622 | -72 | -2.7% | 635,200 |
2021/11/18 | 2,750 | 2,750 | 2,654 | 2,694 | -59 | -2.1% | 485,500 |
2021/11/17 | 2,839 | 2,839 | 2,743 | 2,753 | -70 | -2.5% | 443,700 |
2021/11/16 | 2,844 | 2,859 | 2,814 | 2,823 | -9 | -0.3% | 255,600 |
2021/11/15 | 2,861 | 2,883 | 2,793 | 2,832 | +6 | +0.2% | 397,100 |
2021/11/12 | 2,850 | 2,890 | 2,815 | 2,826 | -7 | -0.2% | 360,200 |
2021/11/11 | 2,839 | 2,863 | 2,816 | 2,833 | -6 | -0.2% | 289,500 |
2021/11/10 | 2,895 | 2,903 | 2,835 | 2,839 | -45 | -1.6% | 449,700 |
2021/11/09 | 2,831 | 2,928 | 2,826 | 2,884 | +45 | +1.6% | 583,700 |
2021/11/08 | 2,820 | 2,874 | 2,810 | 2,839 | +28 | +1% | 669,000 |
2021/11/05 | 2,703 | 2,835 | 2,690 | 2,811 | +112 | +4.1% | 779,900 |
2021/11/04 | 2,698 | 2,750 | 2,675 | 2,699 | +14 | +0.5% | 471,100 |
2021/11/02 | 2,698 | 2,711 | 2,642 | 2,685 | -23 | -0.8% | 631,500 |
701~
750
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム